SU 11274 ; (3z)-n-(3-chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1h-pyrrol-2-yl}methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide ; PKI-SU11274 ; N-(3-Chlorophenyl)-N-methyl-3-[[3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl]methylene]-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide ;
Description
Met Kinase Inhibitor is a pyrrole indolinone compound acting as an ATP-competitive inhibitor of Met kinase activity. Met Kinase Inhibitor shows great (>60-fold) selectivity over Flk and Ron, FGFR-1, c-Src, Cdk2, PDGFRβ, EGFR, and Tie-2 (>400-fold). Met Kinase Inhibitor demonstrated inhibitory effects on HGF/SF-stimulated cellular signaling and Med-mediated tumorigenisis.